Workflow
Seres Therapeutics(MCRB) - 2025 Q1 - Earnings Call Transcript

Seres Therapeutics (MCRB) Q1 2025 Earnings Call May 07, 2025 08:30 AM ET Company Participants Carlo Tanzi - Vice President, Investor Relations and Corporate CommunicationsEric Shaff - President and CEOMarella Thorell - Executive VP & CFOCaroline Pötsch-Hennig - Managing DirectorDennis Walling - Senior Vice President of Clinical DevelopmentMatthew Henn - Executive VP & Chief Scientific Officer Conference Call Participants Joseph Thome - Managing Director, Senior Biotechnology AnalystJohn Newman - Analyst Ope ...